NPI: 1932127800 · RED BLUFF, CA 96080 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/18/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 07/18/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 5,123 | $435K |
| 2019 | 5,650 | $702K |
| 2020 | 8,799 | $585K |
| 2021 | 8,936 | $573K |
| 2022 | 8,088 | $587K |
| 2023 | 9,482 | $632K |
| 2024 | 524 | $312K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,441 | 2,367 | $3.69M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 74 | 74 | $65K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 8,297 | 705 | $23K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 373 | 215 | $18K |
| J1756 | Injection, iron sucrose, 1 mg | 2,292 | 571 | $9K |
| J1270 | Injection, doxercalciferol, 1 mcg | 1,200 | 122 | $9K |
| A4657 | Syringe, with or without needle, each | 3,581 | 1,135 | $9K |
| 83970 | 399 | 372 | $643.56 | |
| 0250 | 1,510 | 92 | $463.58 | |
| 90674 | 48 | 47 | $136.68 | |
| 85041 | 635 | 585 | $0.00 | |
| 85048 | 635 | 585 | $0.00 | |
| 83540 | 279 | 252 | $0.00 | |
| 82108 | 28 | 28 | $0.00 | |
| 83550 | 213 | 189 | $0.00 | |
| 82728 | 273 | 252 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 245 | 229 | $0.00 |
| 82746 | 14 | 14 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 14 | 14 | $0.00 |
| 86706 | 13 | 12 | $0.00 | |
| 84540 | 12 | 12 | $0.00 | |
| 87340 | 13 | 12 | $0.00 | |
| 86704 | 13 | 12 | $0.00 |